Hyperactivity of osteoclast precursors in acute charcot osteoarthropathy

Hyperactivity of osteoclast precursors in acute charcot osteoarthropathy

Bibliographic Details
Main Authors:	Mabilleau, G, Petrova, N, Edmonds, M, Sabokbar, A
Format:	Journal article
Published:	2008

Similar Items

RANKL plays an important role as activator of osteoclastic bone resorption in acute Charcot osteoarthropathy
by: Petrova, N, et al.
Published: (2007)

Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand
by: Mabilleau, G, et al.
Published: (2008)

Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
by: Mabilleau, G, et al.
Published: (2008)

Increased percentage of CD14+monocytes in acute Charcot osteoarthropathy
by: Petrova, N, et al.
Published: (2008)

The number of CD14+osteoclast precursors in acute charcot patients is correlated to the serum levels of tnf-alpha
by: Mabilleau, G, et al.
Published: (2009)

Number of circulating CD14-positive cells and the serum levels of TNF-α are raised in acute charcot foot.
by: Mabilleau, G, et al.
Published: (2011)

The Evaluation of SPECT-CT in the Early Management of Acute Charcot Osteoarthropathy (CN)
by: Raju S. Ahluwalia FRCS (Tr&Orth), MBBS, BSc, et al.
Published: (2016-08-01)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
by: Mabilleau, G, et al.
Published: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
by: Mabilleau, G, et al.
Published: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
by: Guillaume Mabilleau, et al.
Published: (2009-01-01)

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause
by: Chandran Vijay, et al.
Published: (2023-04-01)

Pathomorphological and pathochemical characteristic of the osteomyelitis focus in patients with diabetic osteoarthropathy (Charcot foot)
by: A. S. Sudnitsyn, et al.
Published: (2022-10-01)

Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy
by: Anastasia Gennad'evna Demina, et al.
Published: (2014-12-01)

Bone Defect Replacement in Diabetic Neuropathic Osteoarthropathy (Charcot Foot): Review
by: Petr S. Bardiugov, et al.
Published: (2023-09-01)

Features of organotopic remodeling of bone tissue and implanted osteoplastic material in Charcot neuro/osteoarthropathy
by: Stanislav A. Osnach, et al.
Published: (2023-08-01)

Salvage of Chronic Therapy‐Resistant Bilateral Charcot Foot Osteoarthropathy with Signs of Osteomyelitis
by: Ariel Kidron, et al.
Published: (2022-07-01)

Humoral factors act directly on circulating osteoclast precursors to control osteoclast formation
by: Hirayama, T, et al.
Published: (2000)

Osteoclast formation from circulating precursors in osteoporosis.
by: Jevon, M, et al.
Published: (2003)

The human osteoclast precursor circulates in the monocyte fraction.
by: Fujikawa, Y, et al.
Published: (1996)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
by: Mabilleau, G, et al.
Published: (2010)

Osteoclast formation from circulating precursors in primary and secondary osteoporosis.
by: Jevon, M, et al.
Published: (2000)

Osteoclastic responses to phase pure hydroxyapatite (HA) and silicon (SI)-substituted HA
by: Mabilleau, G, et al.
Published: (2007)

Gender- and age-related differences in osteoclast formation from circulating precursors.
by: Jevon, M, et al.
Published: (2002)

Osteoclast precursors at sites of pathological bone resorption are CD14+mononuclear phagocytes
by: Danks, L, et al.
Published: (2001)

Hypertrophic osteoarthropathy
by: Gang Wang, et al.
Published: (2023-02-01)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
by: Mabilleau, G, et al.
Published: (2011)

Early diagnosis of Charcot neuro-osteoarthropathy using MRI and its effect on patient outcomes: A seven-year retrospective audit
by: Laksh Lukkhoo, et al.
Published: (2024-07-01)

1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors.
by: Itonaga, I, et al.
Published: (1999)

Primary hypertrophic osteoarthropathy
by: E. L. Trisvetova
Published: (2020-11-01)

Osteoarthropathy of the front thorax
by: Nikolay V. Bunchuk
Published: (2023-01-01)

Primary idiopathic osteoarthropathy
by: Dhia Kaffel, et al.
Published: (2017-09-01)

TREATMENT OF DIABETIC OSTEOARTHROPATHY WITH THE ILIZAROV METHOD
by: A. S. Sudnitsyn, et al.
Published: (2021-03-01)

Major sex and age differences in human osteoclast formation from circulating precursors: Implications for the pathogenesis of primary osteoporosis
by: Fujikawa, Y, et al.
Published: (1999)

Pierre Robin Syndrome with Osteoarthropathy
by: V. S. Singh, et al.
Published: (1988-04-01)

Gender differences in 1,25-dihydroxyvitamin D3 effects on osteoclast formation from circulating and bone marrow precursors.
by: Jevon, M, et al.
Published: (2001)

Diagnostic significance of magnetic resonance symptoms in the differential diagnosis of the diabetic osteoarthropathy and osteomyelitis complicating the diabetic osteoarthropathy
by: A. N. Ageev, et al.
Published: (2021-05-01)

TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
by: Mahoney, D, et al.
Published: (2008)

TSG-6 regulates bone remodelling through inhibition of osteoblastogenesis and osteoclast activation
by: Mahoney, D, et al.
Published: (2008)

Hypertrophic osteoarthropathy in a sheep
by: Hisadora Advincula da Silva Chaves Bom, et al.
Published: (2020-10-01)

Coexistence of hypertrophic osteoarthropathy and myelofibrosis
by: Bayram Kelle, et al.